Expressions of Interest for Round 1 have now closed. Applicants will be advised of their project status, week commencing 16 September.
The Biomedical Translation Bridge program is an initiative of the Medical Research Future Fund, providing up to $1 million in matching funding to nurture the translation of new therapies, technologies and medical devices through to the proof of concept stage.
The BTB program is operated by MTPConnect, in partnership with BioCurate (University of Melbourne and Monash University), UniQuest (University of Queensland through its drug discovery initiative QEDDI), the Medical Device Partnering Program (MDPP, led by Flinders University), and the Bridge and BridgeTech programs (Queensland University of Technology); all pre-eminent organisations engaged in the translation and commercialisation of health and medical research.
Contact BTB Program Operations and Event Manager Danielle Shand on 0427 197 448 for more information.
Listen to our podcast for our live Information Session at the Victorian Comprehensive Cancer Centre (VCCC) in Melbourne.